Learning Center
Webinars
-
Contains 3 Component(s), Includes Credits Includes a Live Web Event on 09/10/2025 at 1:00 PM (EDT)
Intravenous (IV) smart pumps revolutionized medication delivery when they were first introduced, dramatically improving precision compared to gravity infusions. However, decades later, the same core technology has not kept pace with the increasing complexity of medications, workflows, and patient needs. This session will trace the evolution of IV smart pumps, explore the factors influencing flow rate accuracy, and discuss why historical designs present challenges in modern clinical contexts. Participants will learn how different pump technologies affect performance and identify practical strategies to minimize risk and enhance patient outcomes.
Intravenous (IV) smart pumps revolutionized medication delivery when they were first introduced, dramatically improving precision compared to gravity infusions. However, decades later, the same core technology has not kept pace with the increasing complexity of medications, workflows, and patient needs. This session will trace the evolution of IV smart pumps, explore the factors influencing flow rate accuracy, and discuss why historical designs present challenges in modern clinical contexts. Participants will learn how different pump technologies affect performance and identify practical strategies to minimize risk and enhance patient outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Articulate what flow rate accuracy means and how it can impact patient safety
• Discuss the types of IV pump technology, their historical development, and their impact on flow rate accuracy
• Describe clinically relevant factors that impact flow rate accuracy
• Discuss strategies for improving patient safety in the context of legacy design constraints and future innovations.Jeannine Blake, PhD, RN
Jeannine Blake, PhD, RN, is a nurse scientist with a clinical background in surgical intensive care nursing and a passion for advancing health care innovation using an interdisciplinary nurse-engineer approach. Her research focuses on improving intravenous (IV) pumping technology accuracy, flow steadiness, and usability, with a current interest in understanding the impact of alarm management on nursing time and patient experience. She is dedicated to improving patient outcomes, streamlining nursing workflows, and integrating IV pumps more effectively into real-world clinical practices.
Dr Blake earned her PhD in Nursing Science and completed a Postdoctoral Research Fellowship in Mechanical and Industrial Engineering at the University of Massachusetts Amherst. She is now an Assistant Professor in the Elaine Marieb College of Nursing and is affiliated with the Elaine Marieb Center for Nursing and Engineering Innovation. She continues her research mission in this role to build evidence that informs infusion practices and optimizes nursing workflows.
Dr Blake contributes to the development of global safety standards for infusion therapy as a member of the Association for the Advancement of Medical Instrumentation (AAMI) technical information report (TIR) Infusion Standards Committee and has been an invited clinical advisor to the International Electrotechnical Commission (IEC) Infusion Standards Working Group. For her work in this space, she is the 2025 AAMI Young Professional Award winner.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: September 10, 2028
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
-
Contains 2 Component(s) Recorded On: 08/14/2025
Join us for an insightful presentation that features a patient’s perspective on living with end-stage kidney disease (ESKD) and experiencing a catheter-related bloodstream infection (CRBSI) while receiving hemodialysis through a central vascular access device (CVAD). Additionally, we will feature the perspective of a Nephrologist who manages these patients and will review the risks of CRBSIs, strategies for prevention, and ways that multi-disciplinary teams can work together to protect patients.
Join us for an insightful presentation that features a patient’s perspective on living with end-stage kidney disease (ESKD) and experiencing a catheter-related bloodstream infection (CRBSI) while receiving hemodialysis through a central vascular access device (CVAD). Additionally, we will feature the perspective of a Nephrologist who manages these patients and will review the risks of CRBSIs, strategies for prevention, and ways that multi-disciplinary teams can work together to protect patients.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Give an understanding of the challenges and risks faced by patients with ESKD who are receiving hemodialysis through a CVAD
• Discuss the risks associated with CRBSIs and their impact on patient health and outcomes
• Explore clinical guidelines for preventing CRBSIs and the potential role of using additional measures such as a catheter lock solution to reduce risk
• Review clinical data on an antimicrobial lock solution that was recently approved by the US Food and Drug Administration
• Discover ways for health care teams to collaborate to prevent CRBSIs and improve patient outcomesThis webinar does not offer any continuing education credits or recertification units.
Anil K. Agarwal, MD, FACP, FASN, FNKF, FISN, FASDIN
Anil K. Agarwal, MD, FACP, FASN, FNKF, FISN, FASDIN, is a Professor of Clinical Medicine at The University of California San Francisco and Academy Professor at Ohio State University, Columbus Ohio. He is also the Deputy Chief of Staff at San Francisco Veterans Affairs Health Care System at Fresno, California. Dr Agarwal is a passionate clinician and educator and is an internationally recognized expert in hypertension, dialysis, anemia, mineral bone disorders, and vascular access. He has conducted over 50 clinical trials, developed protocols, and published results of studies. He is a frequently sought speaker nationally and internationally.
Dr Agarwal is Past President of the American Society of Diagnostic and Interventional Nephrology and Past Chair of the Interventional Nephrology Workgroup of the International Society of Nephrology (ISN). He has been an ISN ambassador to many countries. He is an advisor to the South Asia Board and a member of the North America and Caribbean Board of the ISN and is a member of the Fellowship Committee of the ISN. He has authored and edited the first textbook of Interventional Nephrology, as well as both editions of NephSAP on Interventional Nephrology published by the American Society of Nephrology, among over 500 publications and presentations.
Dr Agarwal serves as editor and reviewer for several medical journals. He chaired many committees and boards, including the Medical Advisory Board of the National Kidney Foundation (NKF) of Ohio and Island Peer Review Organization (Renal Network of Ohio, Kentucky, and Indiana). He was the inaugural Chair of Clinical Scholarship for FAME at Wexner Medical Center from 2014 to 2020.
Celina Medina
Celina Medina is a 2-times kidney recipient. She was diagnosed with Nephrotic Syndrome at the age of 1 ½ years. She received her first kidney transplant when she was a young mother, at 26 years old. The life-saving gift came from a living related donor, her younger brother, Tony. After a successful transplant, Ms Medina was able to give birth to another beautiful daughter. Unfortunately, after 7 years, she returned to dialysis. This time around, while waiting for her peritoneal catheter to mature, she was rushed to the hospital with a severe infection. The infection was severe enough that she spent 3 days in the intensive care unit (ICU). After aggressive antibiotics, she was able to have a full recovery. She spent the next 12 years on dialysis and, finally, on May 25th of 2019, she received her 2nd transplant from an Angel Donor. Ms Medina now dedicates her time sharing her story throughout the country and advocating for organ donation. As a social worker, she spends her days helping the less fortunate, individuals experiencing homelessness, by getting them off the streets.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits Recorded On: 07/16/2025
Oncology nurses are at risk for negative health effects of exposure to hazardous chemotherapy drugs. The health effects of this occupational exposure include the increased risk for cancer, fertility problems, asthma, nausea, vomiting, and allergic reactions. Chemotherapy exposure occurs due to inadvertent contact with these drugs during handling procedures. While the rates of exposure to chemotherapy have decreased since the publication of hazardous drugs handling guidelines in the 1980s, nurses are still reporting exposure incidents. In this session, we will describe the patterns of exposure to chemotherapy and handling practices among oncology nurses based on results from a pilot survey study. Further, we will discuss the factors influencing the exposure and strategies to foster chemotherapy safety from the perspectives of nurses and nurse managers.
Oncology nurses are at risk for negative health effects of exposure to hazardous chemotherapy drugs. The health effects of this occupational exposure include the increased risk for cancer, fertility problems, asthma, nausea, vomiting, and allergic reactions. Chemotherapy exposure occurs due to inadvertent contact with these drugs during handling procedures. While the rates of exposure to chemotherapy have decreased since the publication of hazardous drugs handling guidelines in the 1980s, nurses are still reporting exposure incidents. In this session, we will describe the patterns of exposure to chemotherapy and handling practices among oncology nurses based on results from a pilot survey study. Further, we will discuss the factors influencing the exposure and strategies to foster chemotherapy safety from the perspectives of nurses and nurse managers.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Identify patterns of exposure to chemotherapy and handling practices among oncology nurses based on results from a pilot survey study
• Describe personal and workplace-related factors affecting hazardous chemotherapy exposure among oncology nurses
• Discuss strategies to foster chemotherapy safety among oncology nurses in health care settingsDania Abu-Alhaija, PhD, RN
Dania Abu-Alhaija, PhD, RN, is an Assistant Professor at the University of Cincinnati College of Nursing in the Population Health Department. She obtained the PhD Degree in Nursing from the University of Cincinnati College of Nursing. Her research interests are related to occupational health for health care workers, particularly exposure to hazardous drugs among nurses. Dr Abu-Alhaija’s work experience includes working in acute- and floor-levels medical-surgical departments, research, and academic settings. She has experience in teaching undergraduate and graduate nursing students in both clinical and didactic courses.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: July 16, 2028
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits Recorded On: 06/03/2025
This session will provide participants with an overview of new and unique targeted treatments for cancer, including mechanism of action, administration guidelines, and toxicity management. The presenter will use a case-based approach to reinforce the pathophysiology of driver mutations.
This session will provide participants with an overview of new and unique targeted treatments for cancer, including mechanism of action, administration guidelines, and toxicity management. The presenter will use a case-based approach to reinforce the pathophysiology of driver mutations.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe the drivers for cancer development
• List 4 targets for cancer treatment
• Outline the side effects of targeted cancer treatmentsChristine Rimkus, APRN, MSN, AOCN
Chris Rimkus has been an oncology nurse for 39 years. She graduated from Southern Illinois University @ Edwardsville with her BSN and then in 1992 obtained her Masters in nursing with a focus in oncology from St. Louis University. Her oncology experiences spans the practice spectrum including; inpatient, outpatient and even home infusion. She has cared for a range of cancer patients from surgical oncology, outpatient infusion, radiation oncology and stem cell transplant. She has been a nurse educator and consultant, offering lectures and clinical consultation to both healthcare professionals and patient/caregiver groups. Currently she works PT as an advanced practice provider at St. Louis University and PT as a chemo consultant for Metro Infusion Centers.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: June 3, 2028
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s), Includes Credits Recorded On: 05/13/2025
Nurse efforts to provide patient education and recommendations may, at times, be insufficient to produce behavioral change. Moreover, attempts to persuade patients to adhere to recommendations may result in agreement lacking in follow-through, or outright opposition. Motivational Interviewing (MI) is a patient-centered, evidence-based communication approach with actionable tools for increasing patient receptivity and adherence to medical information and recommendations. This webinar will provide an overview and live demonstration of a specific MI-based communication framework called Ask—Offer—Ask (AOA). Nurses will learn how to apply the AOA approach to share medical information and advice in a way that avoids lecturing and increases patient receptivity and reduces defensiveness.
Nurse efforts to provide patient education and recommendations may, at times, be insufficient to produce behavioral change. Moreover, attempts to persuade patients to adhere to recommendations may result in agreement lacking in follow-through, or outright opposition. Motivational Interviewing (MI) is a patient-centered, evidence-based communication approach with actionable tools for increasing patient receptivity and adherence to medical information and recommendations. This webinar will provide an overview and live demonstration of a specific MI-based communication framework called Ask—Offer—Ask (AOA). Nurses will learn how to apply the AOA approach to share medical information and advice in a way that avoids lecturing and increases patient receptivity and reduces defensiveness.
Learning Objectives: At the conclusion of this session, learners will be able to:
- Describe the Ask—Offer—Ask (AOA) framework and compare/contrast with traditional advice-giving
- Explain how to apply the AOA approach to sharing medical education and recommendations with patients
- Identify clinical opportunities to apply the AOA framework
Valerie Hoover, PhD
Valerie Hoover, PhD, is a licensed clinical psychologist in California. She completed her PhD in Clinical Psychology at the University of Florida, with an emphasis in clinical health psychology and health behavior change. She then completed her clinical residency at Rush University Medical Center in Chicago and postdoctoral fellowship at the San Francisco VA Medical Center. In 2015, Dr Hoover joined the clinical faculty at Stanford University, School of Medicine, Division of Cardiovascular Medicine. In her role at Stanford, in addition to seeing patients and consulting with health care teams, she also provided Motivational Interviewing (MI) training with medical professionals in Cardiovascular Medicine, Primary Care, Clinical Nutrition Services, and Genetic Counseling. In 2017, Dr Hoover was inducted into the Motivational Interviewing Network of Trainers (or MINT), which was established in 1997 by the founders of Motivational Interviewing and is the foremost professional home and certifying organization for MI trainers. She currently serves as an Adjunct Clinical Instructor at Stanford University, Department of Psychiatry and Behavioral Sciences; sees patients in her private practice; and works with health care organizations to bring Motivational Interviewing training to their health care workforce.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: May 13, 2028
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information